Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder.

Berlin HA, Koran LM, Jenike MA, Shapira NA, Chaplin W, Pallanti S, Hollander E.

J Clin Psychiatry. 2011 May;72(5):716-21. doi: 10.4088/JCP.09m05266gre. Epub 2010 Aug 10.

PMID:
20816027
2.

Deep brain stimulation for intractable obsessive compulsive disorder: pilot study using a blinded, staggered-onset design.

Goodman WK, Foote KD, Greenberg BD, Ricciuti N, Bauer R, Ward H, Shapira NA, Wu SS, Hill CL, Rasmussen SA, Okun MS.

Biol Psychiatry. 2010 Mar 15;67(6):535-42. doi: 10.1016/j.biopsych.2009.11.028. Epub 2010 Feb 8.

3.

Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience.

Greenberg BD, Gabriels LA, Malone DA Jr, Rezai AR, Friehs GM, Okun MS, Shapira NA, Foote KD, Cosyns PR, Kubu CS, Malloy PF, Salloway SP, Giftakis JE, Rise MT, Machado AG, Baker KB, Stypulkowski PH, Goodman WK, Rasmussen SA, Nuttin BJ.

Mol Psychiatry. 2010 Jan;15(1):64-79. doi: 10.1038/mp.2008.55. Epub 2008 May 20.

4.

Florida Obsessive-Compulsive Inventory: development, reliability, and validity.

Storch EA, Kaufman DA, Bagner D, Merlo LJ, Shapira NA, Geffken GR, Murphy TK, Goodman WK.

J Clin Psychol. 2007 Sep;63(9):851-9. Erratum in: J Clin Psychol. 2007 Dec;63(12):1265. Kaufman, David A S [added].

PMID:
17674398
5.

Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming.

Okun MS, Mann G, Foote KD, Shapira NA, Bowers D, Springer U, Knight W, Martin P, Goodman WK.

J Neurol Neurosurg Psychiatry. 2007 Mar;78(3):310-4. Epub 2006 Sep 29.

6.

Effect of comorbid tics on a clinically meaningful response to 8-week open-label trial of fluoxetine in obsessive compulsive disorder.

Husted DS, Shapira NA, Murphy TK, Mann GD, Ward HE, Goodman WK.

J Psychiatr Res. 2007 Apr-Jun;41(3-4):332-7. Epub 2006 Jul 24.

PMID:
16860338
7.

Clinical predictors of early fluoxetine treatment response in obsessive-compulsive disorder.

Storch EA, Larson MJ, Shapira NA, Ward HE, Murphy TK, Geffken GR, Valerio H, Goodman WK.

Depress Anxiety. 2006;23(7):429-33.

PMID:
16841343
8.

Is speeding a form of gambling in adolescents?

Husted DS, Gold MS, Frost-Pineda K, Ferguson MA, Yang MC, Shapira NA.

J Gambl Stud. 2006 Jun;22(2):209-19. doi: 10.1007/s10899-006-9011-y. Epub 2006 Jun 29.

PMID:
16807796
9.

Long-term habituation of the smile response with deep brain stimulation.

Springer US, Bowers D, Goodman WK, Shapira NA, Foote KD, Okun MS.

Neurocase. 2006 Jun;12(3):191-6.

PMID:
16801154
10.

Panic and fear induced by deep brain stimulation.

Shapira NA, Okun MS, Wint D, Foote KD, Byars JA, Bowers D, Springer US, Lang PJ, Greenberg BD, Haber SN, Goodman WK.

J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):410-2.

11.

The neurocircuitry of obsessive-compulsive disorder and disgust.

Husted DS, Shapira NA, Goodman WK.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 May;30(3):389-99. Epub 2006 Jan 27. Review.

PMID:
16443315
12.

Pulse-loaded intravenous clomipramine in treatment-resistant obsessive-compulsive disorder.

Koran LM, Aboujaoude E, Ward H, Shapira NA, Sallee FR, Gamel N, Elliott M.

J Clin Psychopharmacol. 2006 Feb;26(1):79-83.

PMID:
16415712
13.

Yale-Brown Obsessive Compulsive Scale: the dimensional structure revisited.

Storch EA, Shapira NA, Dimoulas E, Geffken GR, Murphy TK, Goodman WK.

Depress Anxiety. 2005;22(1):28-35.

PMID:
16130118
14.

What's in a "smile?" Intra-operative observations of contralateral smiles induced by deep brain stimulation.

Okun MS, Bowers D, Springer U, Shapira NA, Malone D, Rezai AR, Nuttin B, Heilman KM, Morecraft RJ, Rasmussen SA, Greenberg BD, Foote KD, Goodman WK.

Neurocase. 2004 Aug;10(4):271-9.

PMID:
15788264
15.

Satiety dysfunction in Prader-Willi syndrome demonstrated by fMRI.

Shapira NA, Lessig MC, He AG, James GA, Driscoll DJ, Liu Y.

J Neurol Neurosurg Psychiatry. 2005 Feb;76(2):260-2.

16.

Disgust and the insula: fMRI responses to pictures of mutilation and contamination.

Wright P, He G, Shapira NA, Goodman WK, Liu Y.

Neuroreport. 2004 Oct 25;15(15):2347-51.

PMID:
15640753
17.

Topiramate in the long-term treatment of binge-eating disorder associated with obesity.

McElroy SL, Shapira NA, Arnold LM, Keck PE, Rosenthal NR, Wu SC, Capece JA, Fazzio L, Hudson JI.

J Clin Psychiatry. 2004 Nov;65(11):1463-9. Erratum in: J Clin Psychiatry. 2005 Jan;66(1):138.

PMID:
15554757
18.
19.

Effects of topiramate in adults with Prader-Willi syndrome.

Shapira NA, Lessig MC, Lewis MH, Goodman WK, Driscoll DJ.

Am J Ment Retard. 2004 Jul;109(4):301-9.

PMID:
15176917
20.

A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder.

Shapira NA, Ward HE, Mandoki M, Murphy TK, Yang MC, Blier P, Goodman WK.

Biol Psychiatry. 2004 Mar 1;55(5):553-5.

PMID:
15023585
21.

Evaluation of open-label topiramate for scar therapy.

Shapira NA, Lessig M, Murphy TK, Annis AM, Lazoritz M.

Dermatol Online J. 2003 Dec;9(5):3.

22.

Brain activation by disgust-inducing pictures in obsessive-compulsive disorder.

Shapira NA, Liu Y, He AG, Bradley MM, Lessig MC, James GA, Stein DJ, Lang PJ, Goodman WK.

Biol Psychiatry. 2003 Oct 1;54(7):751-6.

PMID:
14512216
23.

Problematic internet use: proposed classification and diagnostic criteria.

Shapira NA, Lessig MC, Goldsmith TD, Szabo ST, Lazoritz M, Gold MS, Stein DJ.

Depress Anxiety. 2003;17(4):207-16.

PMID:
12820176
24.

Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.

McElroy SL, Arnold LM, Shapira NA, Keck PE Jr, Rosenthal NR, Karim MR, Kamin M, Hudson JI.

Am J Psychiatry. 2003 Feb;160(2):255-61. Erratum in: Am J Psychiatry. 2003 Mar;160(3):612.

PMID:
12562571
25.

Topiramate attenuates self-injurious behaviour in Prader-Willi Syndrome.

Shapira NA, Lessig MC, Murphy TK, Driscoll DJ, Goodman WK.

Int J Neuropsychopharmacol. 2002 Jun;5(2):141-5. doi: 10.1017/S1461145702002833.

PMID:
12135538
26.

Topiramate for reversing atypical antipsychotic weight gain.

Lessig MC, Shapira NA, Murphy TK.

J Am Acad Child Adolesc Psychiatry. 2001 Dec;40(12):1364. No abstract available.

PMID:
11765278
27.

Hypersexual disorder and preoccupation with internet pornography.

Stein DJ, Black DW, Shapira NA, Spitzer RL.

Am J Psychiatry. 2001 Oct;158(10):1590-4. No abstract available.

PMID:
11578986
28.

The psychobiology of obsessive-compulsive disorder: how important is the role of disgust?

Stein DJ, Liu Y, Shapira NA, Goodman WK.

Curr Psychiatry Rep. 2001 Aug;3(4):281-7. Review.

PMID:
11470034
29.

Treatment of refractory major depression with tramadol monotherapy.

Shapira NA, Verduin ML, DeGraw JD.

J Clin Psychiatry. 2001 Mar;62(3):205-6. No abstract available.

PMID:
11305709
30.

Treatment of binge-eating disorder with topiramate: a clinical case series.

Shapira NA, Goldsmith TD, McElroy SL.

J Clin Psychiatry. 2000 May;61(5):368-72.

PMID:
10847312
31.

Psychiatric features of individuals with problematic internet use.

Shapira NA, Goldsmith TD, Keck PE Jr, Khosla UM, McElroy SL.

J Affect Disord. 2000 Jan-Mar;57(1-3):267-72.

PMID:
10708842
32.

Evaluation of bipolar disorder in inpatients with prelingual deafness.

Shapira NA, DelBello MP, Goldsmith TD, Rosenberger BM, Keck PE Jr.

Am J Psychiatry. 1999 Aug;156(8):1267-9.

PMID:
10450272
33.

Rapid remission of OCD with tramadol hydrochloride.

Goldsmith TB, Shapira NA, Keck PE Jr.

Am J Psychiatry. 1999 Apr;156(4):660-1. No abstract available.

PMID:
10200754
34.

Novel use of tramadol hydrochloride in the treatment of Tourette's syndrome.

Shapira NA, McConville BJ, Pagnucco ML, Norman AB, Keck PE Jr.

J Clin Psychiatry. 1997 Apr;58(4):174-5. No abstract available.

PMID:
9164430
35.

Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder.

Shapira NA, Keck PE Jr, Goldsmith TD, McConville BJ, Eis M, McElroy SL.

Depress Anxiety. 1997;6(4):170-3. No abstract available.

PMID:
9559288
36.

Neuroexcitation, excitotoxicity and human neurological disease.

Whetsell WO Jr, Shapira NA.

Lab Invest. 1993 Apr;68(4):372-87. Review. No abstract available.

PMID:
8479146
37.

Protein bound to mitochondrial DNA from tumor and normal tissues of humans and animals.

Shapira NA, Kinkade JM Jr, Shapira R.

Cancer Biochem Biophys. 1988 Jul;10(1):77-84.

PMID:
3224333

Supplemental Content

Loading ...
Support Center